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insertion/deletion and angiotensinogen M235T polymorphismsAngiotensin I-converting enzyme gene insertion/deletion and
contribute to the increased risk for the development of CRF,angiotensinogen M235T polymorphisms: Risk of chronic renal
but the magnitude of the effect within subsets of patients withfailure.
specific etiologies of CRF must be evaluated further.Background. Chronic renal failure (CRF) is a complex phe-
notype that results from an underlying kidney disease and
superimposing environmental and genetic factors. The aim of
our study was to evaluate the role of polymorphisms in the
Epidemiological data have suggested that only a mi-genes encoding for components of the renin-angiotensin system
nority of patients with kidney diseases caused by diabetes(RAS) in the development and/or progression of CRF.
Methods. Two hundred forty-seven family trios (patients mellitus, hypertension, and chronic glomerular diseases
with CRF and both parents; 120 with primary chronic glomeru- are susceptible to the complication of progressive renal
lonephritis, 80 with interstitial nephritis, and 47 with type 1
failure and finally to end-stage renal disease (ESRD).diabetes with nephropathy) were examined, and transmission/
Racial differences, socioeconomic status, and environ-disequilibrium test (TDT) was used to evaluate allele transmis-
sion from heterozygous parents to affected offspring. mental factors, although they are present, do not explain
Results. The D allele of the angiotensin I-converting enzyme the markedly increased risk for renal disease in these
(ACE) gene insertion/deletion polymorphism was transmitted patients. Familial clustering, which has been reportedsignificantly more frequently than expected for no association
for a variety of common renal diseases as well as foramong all examined trios and in the subgroup of patients with
chronic renal failure (CRF) itself, supports the con-interstitial nephritis. The angiotensinogen 235T allele was
transmitted significantly more frequently to patients with CRF tention that genetic factors play an important role in
than expected for no association, but the effect was seen only their development [1–7]. Thus, the interactions between
in patients with interstitial nephritis. The presence of the DD
multiple genetic and environmental factors are thoughtor ID genotype was associated with a faster rate of decline of
to be involved in the process of progressive renal damagerenal function, which was not observed for the angiotensinogen
M235T polymorphism. For chymase gene and angiotensin II in the course of various kidney diseases.
receptor type 1 gene, allele transmission did not deviate signifi- More recently, there has been great interest in the
cantly from a random proportion of 50:50%. role of polymorphisms in the genes encoding for compo-Conclusions. The results of this study suggest that ACE gene
nents of the renin-angiotensin system (RAS) in the de-
velopment and/or progression of renal diseases, but the
1 The End-Stage Renal Disease Study Group: W. Trautsolt, S. Gorczyn- data available in this area still remain conflicting [8–12].ska, I. Szydlowska, and B. Gawlik (Department of Internal Medicine and
Angiotensinogen (AGT), angiotensin I-converting en-Diabetology, Zabrze); B. Rutkowski and P. Rutkowski (Department of
Nephrology, Gdansk); M. Klinger (Department of Nephrology, Wro- zyme (ACE), and angiotensin II type 1 receptor (AT1)
claw); D. Zwolinska (Department of Pediatric Nephrology, Wroclaw); receptor genes have long been considered candidatesO. Smolenski (Nephrology and Dialysis Center, Krakow); R. Baczynski
that contribute to cardiovascular diseases, especially toand R. Drabczyk (Nephrology and Dialysis Center, Bielsko-Biala); K.
Szprynger (Silesian Center of Pediatrics, Zabrze). essential hypertension. These observations are now of
particular relevance in renal diseases, since proteins en-Key words: renin-angiotensin system, end-stage renal disease, gene
polymorphism, progressive kidney disease, heredity. coded by these genes are involved not only in the regula-
tion of systemic blood pressure, but also in the regulation
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sion/disequilibrium test (TDT) [17, 18]. The TDT test, We excluded family trios with probands with ESRD
attributed to polycystic kidney disease or other heritablefirst introduced by Spielman, McGinnis, and Ewens, ex-
amines the transmission of a particular molecular variant conditions (for example, Alport’s syndrome) and un-
known or uncommon etiologies. A detailed history of(allele) from heterozygous parents to affected offspring,
and the observed transmission is compared with the kidney disease was collected from all patients, and all
parents provided basic epidemiological data according totransmission expected for no association (that is, random
transmission of 50:50% for two-allele systems) [17]. our standardized questionnaire. All patients and parents
gave their written informed consent, and the study proto-This article reports the results of a family-based study
that investigated the role of polymorphisms in the genes col was approved by the Ethics Committee of the Silesian
School of Medicine.encoding for components of the RAS, including AGT
M235T polymorphism, ACE insertion/deletion (I/D)
DNA analysispolymorphism, chymase gene CMA/B polymorphism,
and AT1 receptor A1166C polymorphism in the devel- From all patients and parents, genomic DNA was iso-
lated from peripheral blood leukocytes.opment and/or progression of CRF. These polymor-
phisms were genotyped in a group of 247 family trios: Angiotensin I-converting enzyme insertion/deletion
genotype was determined according to standard protocoloffspring affected with ESRD and both parents.
[20]. In the DD homozygotes, additional amplification
using insertion-specific primers was performed to avoid
METHODS
the mistyping of the ID genotype because of the prefer-
Selection of family trios ential amplification of the D allele.
Angiotensinogen M235T polymorphism was geno-A detailed method of collecting of families for the
study has been presented elsewhere [19]. typed with a method similar to that described by Doria
et al [21]. Three hundred fifty-four bp of exon 2 wereBriefly, subjects for the study were recruited from 17
nephrology or dialysis centers in Poland. Overall, 1657 amplified with primers 59-GAT GCG CAC AAG GTC
CTG TC and 59-GCGCGC GCC AGC AGA GAG GTTCaucasian patients who had a history of ESRD (creati-
nine clearance ,30 mL/min) or who were submitted TGC CT; five minutes of initial denaturation in 958C
was followed by 30 cycles of one minute in 958C, oneto chronic hemodialysis or peritoneal dialysis with the
etiologies of ESRD: primary glomerulonephritis, 729; minute in 558C, and one minute in 728C. Ten microliters
of polymerase chain reaction (PCR) product were elec-interstitial nephritis, 263; diabetic nephropathy, 170; hy-
pertension, 116; polycystic kidney disease, 40; and other trophoresed on a 10% polyacrylamide gel (acrylamide/
bis, 37.5:1) with a linear gradient of denaturants fromcauses and unknown etiology, 234 were identified. For
further family-based association comparisons, 247 pa- 40 to 60% (100% 5 7 mol/L urea and 40% formamide),
in 1 3 TAE buffer at 608C, 10 V/cm for 4.5 hours. MMtients who had both parents alive and who agreed to
participate in the study were selected: 120 with primary homozygotes were detected as a single band at 48% of
denaturant concentration, TT homozygotes as a singleglomerulonephritis, 80 with interstitial nephritis (includ-
ing chronic pyelonephritis), and 47 patients with ESRD band at 48.5%, while heterozygotes as four bands, 48
and 48.5%, with two heteroduplexes melting at lowercaused by diabetic nephropathy in type 1 diabetes. Pri-
mary glomerulonephritis was diagnosed on the basis of denaturant concentrations.
Chymase gene CMA/B polymorphism was determinedrenal biopsy in 37 cases (30.8%), while in the remaining
83 patients the diagnosis was based on the clinical pic- as described by Pfeufer et al [22]. Amplification primers
for the 285 bp fragment of the 59 untranscribed regionture: proteinuria, nephritic urinary sediment, usually hy-
pertension, and insidious loss of renal function. Intersti- were 59-GGA AAT GTG AGC AGA TAG TGC AGTC
and 59-AAT CCG GAG CTG GAG AAC TCT TGTC.tial nephritis was diagnosed if recurrent urinary tract
infections, an abnormal urogram showing a dilated caly- After five minutes of denaturation in 958C, 39 cycles of
30 seconds in 948C, 15 seconds in 518C, and 30 secondsceal system with an overlying scar, and urinary sediment
changes were present. Diabetic nephropathy was defined in 728C were performed. Ten microliters of the PCR
product were digested with 2 U of BstXI (New Englandas persistent proteinuria ($500 mg/day) unexplained by
other urinary tract disease. None of the examined par- Biolabs, Beverly, MA, USA). CMA/B G allele was pre-
sented on 3% agarose as 195 and 90 bp bands, whereasents presented a documented renal dysfunction, while
hypertension (defined as a systolic blood pressure $140 A allele remained uncut.
The AT1 receptor gene A1166C polymorphism wasmm Hg and/or diastolic blood pressure $90 mm Hg
documented in the medical records on at least two sepa- detected with a method similar to that described by Do-
ria, Warram, and Krolewski [23]. Five minutes of dena-rate occasions, or antihypertensive treatment) was pres-
ent in 6.9% (N 5 17) and 5.2% (N 5 13) of the examined turation in 958C followed by 30 cycles of one minute in
948C, one minute in 558C, one minute in 728C with prim-mothers and fathers, respectively.
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ers 59-CGA CTA CTG CTT AGC ATA and 59-GCA RESULTS
CCA TGT TTT GAG GTT resulted with a 546 bp PCR Among 247 cases included into the study, 144 patients
product (from the untranscribed 39 region of the gene). were submitted to hemodialysis, while 13 were submitted
Upon cleavage with 14 U of DdeI (Boehringer Mann- to peritoneal dialysis, with a median duration of dialysis
heim, Mannheim, Germany) and electrophoresed on 3% of 2.0 years (0.0 to 8.0). Ninety patients had a median
creatinine clearance (calculated according to the Cock-agarose, allele A2 produced two bands at 435 and 111
croft-Gault formula) of 14.5 mL/min (8.4 to 27.5) forbp, while the A1 allele remained undigested.
women and 17.3 mL/min (12.6 to 27.7) for men and wereFor all polymorphisms tested in the study, PCR was
in the predialysis period. Mean age, body mass index,performed from 100 to 300 ng of genomic DNA in 50 mL
median serum creatinine, and median creatinine clear-volume, with 10 pmol of the specific primers, 20 U/mL
ance (calculated according to the Cockcroft-Gault for-of PrimeZyme DNA polymerase (Biometra, Go¨ttingen,
mula for patients in the predialysis period) of the exam-Germany), 1.5 mmol/L MgCl2, 2.5 mmol/L of each dNTP,
ined patients, as well as the proportion of genders andin one of the following cyclers: UNO II (Biometra)
hypertension in our study group, are presented in Tableor Mastercycler Gradient (Eppendorf, Hamburg, Ger-
1. Allele transmission of the examined polymorphisms,many).
as well as number of informative trios, is presented in
Table 2. Allele frequencies of the examined polymor-Statistical analysis
phisms in the study subgroups are presented in Table 3.
Basic epidemiological data describing the study pa- The D allele of the ACE insertion/deletion polymor-
tients are presented as mean and standard deviation for phism was transmitted to affected offspring more often
normally distributed continuous variables, while for vari- than expected for no association among all examined
ables not distributed normally, we presented median and trios and in the interstitial nephritis group (P , 0.05).
Moreover, the presence of the DD or ID genotype wasquartiles. In the TDT, we used McNemar’s test to com-
associated with a faster rate of decline of renal functionpare the observed transmission of alleles from heterozy-
compared with the homozygous II genotype, and thegous parents to affected offspring with an expected ratio
association reached statistical significance when all sub-of 50:50 transmission for alleles not associated with the
jects with CRF were combined in one group (Fig. 1),phenotype. For 136 patients, a retrospective history of
as well as in the subgroup of subjects with interstitialrepeated measurements of serum creatinine from the
nephritis (P , 0.05; Fig. 2). In the interstitial nephritisonset of chronic kidney disease with serum creatinine
subgroup, we observed the AGT 235T allele being trans-below 1.5 mg/dL, who were followed for a period of
mitted significantly more often than the 235M allele (P ,at least one year, with at least five consecutive serum
0.01). However, in that case, no impact of this polymor-
creatinine measurements, was available. In this group, phism on the rate of progression of renal function loss
the median of first documented serum creatinine concen- was observed.
tration at the diagnosis of kidney disease was 1.0 mg/dL For CMA/B and AT1 polymorphisms, allele transmis-
(quartiles, 0.8 to 1.3), and the mean age of the patients sion did not differ from the expected random proportion
at time the study was performed was 25.4 6 10.7 years. of 50:50, with no significant variation in the slope of
The longest documented duration of kidney disease from reciprocal serum creatinine over time between the exam-
its onset till the beginning of renal replacement therapy ined genotypes.
or time of performing the study (for conservatively
treated patients) was 20 years, and such a duration was
DISCUSSION
present in 11 patients. For each patient, the reciprocal
In this study, we examined the association betweenserum creatinine concentration was plotted versus time
polymorphisms in the genes encoding for componentsbetween measurements by means of the least-squares
of RAS: ACE, AGT, chymase, and AT1 receptor, withregression method. For each case, such a plot fitted the
the development of CRF in the course of chronic glomer-
model of linear regression, with correlation coefficients ulonephritis, interstitial nephritis, and diabetic nephrop-
varying from 20.884 to 20.997 (P , 0.05), and the slope athy. To avoid the potential bias of case-control studies,
was used to define the rate of progression of renal func- we applied a family-based study design, namely TDT,
tion loss. Mean regression coefficients were compared which evaluates the transmission of associated alleles
between subgroups of patients carrying different geno- from heterozygous parents to offspring affected with the
types in the examined loci using the parallelity test. examined phenotype. We have demonstrated the excess
All calculations were performed in Excel 97 spread- transmission of the ACE insertion/deletion D allele to
sheet (Microsoft, Seattle, WA, USA) and Statistica Re- offspring affected with CRF. The significant effect was
seen when the examined trios were combined in onelease 5.0 for Windows (StatSoft Inc., Tulsa, OK, USA).
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Table 1. Selected clinical data of the affected offspring analyzed in the TDT test
Total GN IN DN
N 247 120 80 47
Female/male 111/136 53/67 36/44 22/25
Age years 26.7612.1 27.5610.9 19.369.8 37.269.8
BMI kg/m2 20.963.9 21.163.6 19.364.1 23.463.3
Serum creatinine mg/dL 8.2 (5.5–9.9) 9.0 (7.4–10.1) 7.1 (3.9–9.1) 7.7 (4.0–9.2)
Creatinine clearance (conservatively treated patients) mL/min
Female 14.5 (8.4–27.5) 8.1 (6.4–9.5) 8.4 (4.1–30.1) 13.3 (7.7–29.9)
Male 17.3 (12.6–27.7) 10.5 (9.0–12.9) 10.6 (8.0–14.9) 11.0 (10.0–17.7)
Hypertension % 196 (79.3%) 108 (90%) 45 (56.25%) 43 (91.5%)
Abbreviations are: TDT, transmission/disequilibrium test; GN, glomerulonephritis; IN, interstitial nephritis; DN, diabetic nephropathy.
Table 2. Allele transmission of the examined polymorphisms from heterozygous parents to offspring affected with chronic renal failure
Total GN IN DN
N (%)
ACE I/D
N of informative trios 170 80 60 30
I transmitted 97 (43%)a 51 (46%) 30 (38%)a 16 (44%)
D transmitted 128 (57%) 60 (54%) 48 (62%) 20 (56%)
AGT M235T
N of informative trios 192 92 69 31
M transmitted 118 (45%) 69 (54%) 34 (36%)b 15 (39%)
T transmitted 141 (55%) 58 (46%) 60 (64%) 23 (61%)
AGTR1 A1A2
N of informative trios 176 88 55 33
A1 transmitted 108 (53%) 62 (56%) 28 (44%) 18 (62%)
A2 transmitted 95 (47%) 49 (44%) 35 (56%) 11 (38%)
CMA/B
N of informative trios 137 73 45 19
A transmitted 126 (51%) 68 (54%) 39 (51%) 19 (45%)
G transmitted 119 (49%) 58 (46%) 38 (49%) 23 (55%)
Abbreviations are: GN, glomerulonephritis; IN, interstitial nephritis; DN, diabetic nephropathy.
aP , 0.05
bP , 0.01
Table 3. Allele frequencies of the examined polymorphisms defined as the slope of reciprocal serum creatinine con-
observed in respective groups of patients affected with
centration over time.chronic renal failure
The AGT 235T allele was more often transmitted to
Total GN IN DN patients with CRF in the course of interstitial nephritis.
% However, in that case, no impact of this sequence differ-
ACE I/D ence on the rate of progression of renal failure was ob-
(I/D) 43/57 46/54 41/59 39/61 served. We observed no significant association between
AGT M235T
the presence of CRF and polymorphisms in the genes(M/T) 50/50 55/45 39/61 54/46
AGTR1 A1A2 encoding for chymase, as well as AT1.
(A1/A2) 71/29 68/22 72/28 78/22 The RAS acts via the effector peptide, angiotensin II,
CMA/B
which affects renal hemodynamics and tubular transport,(A/G) 60/40 60/40 61/39 57/43
stimulates cytokine formation and release, also havingAbbreviations are: GN, glomerulonephritis; IN, interstitial nephritis; DN,
diabetic nephropathy. inflammatory properties [14–16]. Angiotensin II is also
regarded as a trophic hormone, stimulating growth and
proto-oncogenes in various renal cell types [13, 24–26].
Angiotensin II may also stimulate ammoniogenesis in
group and among patients with interstitial nephritis. A renal tubular cells, which in turn stimulates tubular hyper-
similar, but not statistically significant, tendency was ob- trophy. Increased ammonia concentrations in the renal
served in chronic glomerulonephritis and diabetic ne- cortex, as a result of activation of the complement cascade
phropathy subgroups. Carriers of the DD or ID genotype by interacting with the complement component C3, can
induce tubulointerstitial disease [15, 27]. Thus, increasedalso experienced a more rapid decline of renal function,
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Fig. 1. Reciprocal creatinine-vs.-time plot and angiotensin I-converting Fig. 2. Reciprocal creatinine-vs.-time plot and ACE gene insertion/
deletion genotypes in patients with CRF due to interstitial nephritis.enzyme (ACE) gene insertion/deletion genotypes in all examined pa-
tients with chronic renal failure (CRF). Symbols are: (j) DD, N 5 49; Symbols are: (j) DD, N 5 18; (m) ID, N 5 18; (d) II, N 5 9. P ,
0.05, DD vs. II and ID vs. II.(m) ID, N 5 67; (d) II, N 5 20. P , 0.05, DD vs. II and ID vs. II.
production of angiotensin II within nephrons and their In contrast, no significant differences in I/D genotype dis-
tributions were found between CRF patients with variousvasculature could participate in local renal injury through
both hemodynamic and nonhemodynamic actions and is underlying renal diseases and healthy control subjects.
In our study, the excess transmission of the D allelea well-established factor promoting renal damage.
Results of previous association studies of ACE poly- was present in all examined subsets of patients with dif-
ferent etiologies of ESRD, but the effect reached signifi-morphism with CRF, performed on unrelated patients,
were inconsistent. Hunley et al found the increased prev- cance when all patients were combined into one group
and in the interstitial nephritis group analyzed sepa-alence of the DD genotype and the D allele in 40 Cauca-
sian patients with IgA nephropathy, who developed pro- rately. This might represent the impact of ACE gene
polymorphism on the risk of the development of CRF,gressive renal dysfunction, compared with 24 patients,
whose renal function remained stable [28]. In the study independent from the underlying kidney disease. It is,
however, very likely that the magnitude of the effect isof Harden et al performed on 100 British Caucasian IgA
nephropathy patients, earlier age of the development as different in different etiological subgroups of patients,
which could not be demonstrated in our analysis becausewell as worse progression of CRF in DD genotype carri-
ers were demonstrated [29]. A tendency toward an in- of the limited number of patients studied.
Hamaguchi et al (abstract; J Am Soc Nephrol, 6:389,crease in the frequency of the DD genotype in the IgA
nephropathy ESRD group, but without statistical sig- 1995) and Hunley et al [28] investigated the role of AGT
M235T polymorphism as a risk factor for a more rapidnificance (P 5 0.07) was observed by Schmidt et al [30].
Similar positive results came from studies on Japanese progression of renal failure in Japanese and Caucasian
populations, respectively, with no positive results. Schmidtpopulation, characterized by the highest prevalence of
IgA nephropathy in the world. Yoshida et al demon- et al demonstrated that IgA nephropathy patients with
the TT genotype had a tendency toward faster progres-strated that the risk of progression to CRF in patients
carrying the DD genotype was nearly fourfold of that sion of renal failure, but the difference did not reach
statistical significance [30]. It would be plausible to spec-in patients with other genotypes [31]. On the other hand,
Yorioka et al found that the presence of the D allele ulate that the T allele of the AGT M235T polymorphism,
being transmitted more frequently to patients with(DD or ID genotype) was associated with a higher rate
of reduction in the glomerular filtration rate [32]. chronic pyelonephritis who developed CRF, is a marker
of the predisposition to terminal complication of thisMcLaughlin et al analyzed 822 patients with variety
of renal diseases and showed a faster progression of renal kidney disease. However, it should be considered that
the observed deviation from random transmission resultsfailure, determined as the slope of the serum creatinine
versus time plot in DD homozygotes, as well as improved from the association with the underlying kidney disease,
rather than from a predisposition to the development ofrenal survival in II homozygotes [33]. When patients
were divided on those with tubulointerstitial and glomer- CRF. Such a hypothesis, however unlikely, can only be
excluded by studying allele transmission to offspring af-ular diseases, the effect was confined to the latter group.
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